Surgery Partners
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Surgery Partners generated cash of $293,800,000, which is more than the previous year. Cash used in financing activities reached the amount of -$155,200,000 last year. Net change in cash is therefore -$87,000,000.
Cash Flow
| 2014 | 21.94M | -271.01M | 310.96M |
|---|---|---|---|
| 2015 | 84.48M | -134.84M | 33.37M |
| 2016 | 125.23M | -184.74M | 71.27M |
| 2017 | 120.94M | -783.44M | 767.72M |
| 2018 | 144.6M | -128.86M | -6.3M |
| 2019 | 129.5M | -85.2M | -135.9M |
| 2020 | 246.9M | -88.4M | 66.7M |
| 2021 | 87.1M | -331.7M | 316.3M |
| 2022 | 158.8M | -307.9M | 42.1M |
| 2023 | 293.8M | -225.6M | -155.2M |
SGRY Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 282.9M | 389.9M | 318.2M | 93M | 184.6M | 175.22M | 57.93M | 57.93M | 74.92M | 13.02M |
Operating activities | ||||||||||
Net income | -11.9M | 87M | 70.7M | 1.3M | 45.1M | -95.62M | -52.98M | 85.08M | 72.84M | -27.05M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 118.1M | 114.8M | 98.8M | 94.8M | 76.5M | 67.44M | 51.92M | 39.55M | 34.54M | 15.06M |
Stock-based compensation expense | 17.7M | 18.4M | 17.4M | 13.2M | 10.2M | 9.34M | 5.6M | 2.02M | 7.50M | 942K |
| Deferred income tax benefit | 17.7M | 18.4M | 17.4M | 13.2M | 10.2M | 9.34M | 5.6M | 2.02M | 7.50M | 942K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -47.2M | -35.3M | -32.1M | -46.6M | -23.5M | -22.81M | -60.62M | -60.62M | -48.78M | -20.16M |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 293.8M | 158.8M | 87.1M | 246.9M | 129.5M | 144.6M | 120.94M | 125.23M | 84.48M | 21.94M |
Investing activities | ||||||||||
Purchases Of Investments | -50.3M | -95.1M | 5.4M | 0 | -15.2M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -88.8M | -80.6M | -57.6M | -42.9M | -73.6M | -39.80M | -29.6M | -39.10M | -33.43M | -9.43M |
Acquisitions Net | -54.2M | -228.7M | -280.4M | -104.6M | -11.4M | -87.60M | -755.10M | -145.64M | -101.40M | -261.58M |
Cash generated by investing activities | -225.6M | -307.9M | -331.7M | -88.4M | -85.2M | -128.86M | -783.44M | -184.74M | -134.84M | -271.01M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 882.9M | 554.2M | 0 | 0 | 0 | 0 | 0 | 250.97M | 1.47B |
Payments for dividends | 0 | 0 | -5.1M | 0 | 0 | -7.8M | -1.31M | 0 | 0 | -93M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -2M | -2M | 0 | 0 | -3.14M |
Repayments of term debt | 19.5M | -644.2M | -43.8M | -216.3M | -1.7M | -125.1M | 565.12M | -478.33M | -135.71M | -1.02B |
Cash used in financing activities | -155.2M | 42.1M | 316.3M | 66.7M | -135.9M | -6.3M | 767.72M | 71.27M | 33.37M | 310.96M |
Net Change In Cash | -87M | -107M | 71.7M | 225.2M | -91.6M | 9.39M | 11.76M | 11.76M | -16.98M | 61.89M |
Cash at end of period | 195.9M | 282.9M | 389.9M | 318.2M | 93M | 184.62M | 69.69M | 69.69M | 57.93M | 74.92M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |